Week Ending March 29, 2021

DAA Therapy Promising for Geriatric Hepatitis C Patients
“Oral antiviral therapy could increase treatment tolerability and response in geriatric patients with chronic hepatitis C virus (HCV) infections.”

COVID Vaccine Side Effects and Hepatitis C and Liver Disease
“Many with hep C or another liver disease have questions about what the side effects of COVID vaccines might be.”

Generalized HCV Screening in Psychiatric Patients May Be Cost-Effective Strategy
“Findings from a new study suggested that screening for hepatitis C (HCV) among all patients admitted for psychiatric hospital visits may be more cost-effective than a risk-based approach.”

Risks Associated with Pegylated Interferon plus Ribavirin Treatment for Hepatitis C
“Treatment with pegylated interferon plus ribavirin (PegIFN/RBV) significantly increased the risk of retinal hemorrhage in people with hepatitis C virus (HCV), according to a paper published in Viruses, while the risk for retinal vascular occlusions was not increased in this population.”

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
“People who inject drugs (PWID) are at increased risk for HIV and hepatitis C virus (HCV) infection and also have high levels of homelessness and unstable housing. We assessed whether homelessness or unstable housing is associated with an increased risk of HIV or HCV acquisition among PWID compared with PWID who are not homeless or are stably housed.”

Nobody puts hepatitis in the corner! Achieving integration of HIV PrEP & viral hepatitis services
“Join our stellar list of speakers as they (1) explore the evidence on the prevalence and incidence of hepatitis C virus among men who have sex with men with a particular focus on implications for PrEP programs, (2) discuss WHO guidance on hepatitis B and C prevention, testing and treatment to support best practices for PrEP programs, and (3) share experiences from implementing HIV PrEP and viral hepatitis services in Asia and Europe, highlighting clinician and community perspectives.”

New National Plan to End Viral Hepatitis
“The Department of Health and Human Services (HHS) recently released the Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021–2025.”

As Long as I Live
“In 2003, Reid went to the hospital for a biopsy and was diagnosed with hepatitis C virus (HCV). Reid didn’t start HCV treatment until a year later, when her doctor put her on an interferon regimen, which required weekly injections.”